PHARMA MAR, S.A. «...678910...» Página 6 de 18 desde 01/07/1988 hasta 27/09/2024 16/10/2018 15:29 PHARMA MAR, S.A. Others on business performance and financial information Pharma Mar´s statement is attached. Número de registro: 270531 04/10/2018 11:23 PHARMA MAR, S.A. Liquidity contracts and specialists The Company reports details of the operations of the Liquidity Agreement between 05/06/2018 and 28/09/2018 Número de registro: 270156 Relacionado con 266399 del 04/06/2018 (17:39) 02/10/2018 08:14 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks Pharma Mar´s application before the General Court of the European Union requesting the annulment of the refusal of the marketing authorisation for Aplidin. Número de registro: 270099 Relacionado con 263165 del 21/03/2018 (19:24) 20/09/2018 14:14 PHARMA MAR, S.A. Transmissions and purchases of capital undertakings The Company announces the sale of its subsidiary Xylazel, S.A. Número de registro: 269749 07/09/2018 08:18 PHARMA MAR, S.A. Other on financial instruments Pharma Mar announces its intention to conduct a registered public offering of American Depositary Shares representing its shares in US Número de registro: 269450 03/08/2018 08:23 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks Lurbinectedin has been granted orphan drug status by the FDA for the treatment of small cell lung cancer. Número de registro: 268855 30/07/2018 16:10 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks Pharma Mar announces that 600 patients have been already recruited in the Phase III clinical trial ATLANTIS in in relapsed small-cell lung cancer with lurbinectedin. Número de registro: 268655 27/07/2018 11:47 PHARMA MAR, S.A. Others on business performance and financial information Execution of an agreement between Pharma Mar and Impilo Pharma for the exclusive promotion and distribution of Yondelis throughout the Nordic countries and Eastern Europe Número de registro: 268553 26/07/2018 17:54 PHARMA MAR, S.A. Information on P&L The Company sends press release regarding first half 2018 results. Número de registro: 268438 26/07/2018 17:49 PHARMA MAR, S.A. Interim financial information La sociedad remite información sobre los resultados del primer semestre de 2018 Número de registro: 268434 Página 6 de 18 «...678910...»